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Abstract
Congenital or familial short QT syndrome is a genetically heterogeneous cardiac channelopathy 
without structural heart disease that has a dominant autosomal or sporadic pattern of trans-
mission affecting the electric system of the heart. Patients present clinically with a spectrum 
of signs and symptoms including irregular palpitations due to episodes of paroxysmal atrial 
fibrillation, dizziness and fainting (syncope) and/or sudden cardiac death due to polymorphic 
ventricular tachycardia and ventricular fibrillation.
Electrocardiographic (ECG) findings include extremely short QTc intervals (QTc interval  
£ 330 ms) not significantly modified with heart rate changes and T waves of great voltage with 
a narrow base. Electrophysiologic studies are characterized by significant shortening of atrial 
and ventricular refractory periods and arrhythmias induced by programmed stimulation.
A few families have been identified with specific genotypes: 3 with mutations in potassium 
channels called SQT1 (Iks), SQT2 (Ikr) and SQT3 (Ik1). These 3 potassium channel variants 
are the “genetic mirror image” of long QT syndrome type 2, type 1 and Andersen-Tawil syndro-
me respectively because they exert opposite gain-of-function effects on the potassium channels 
in contrast to the loss-of-function of the potassium channels in the long QT syndromes. Three 
new variants with overlapping phenotypes affecting the slow inward calcium channels have 
also been described. Finally, another variant with mixed phenotype affecting the sodium chan-
nel was reported. This review focuses the landmarks of this newest arrhythmogenic cardiac 
channelopathy on the main clinical, genetic, and proposed ECG mechanisms.  In addition the-
rapeutic options and the molecular autopsy of this fascinating primary electrical heart disease 
are discussed. (Cardiol J 2013; 20, 5: 464–471)
Key words: congenital short QT syndrome, historical landmarks,  
channelopathies
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Introduction
Congenital short QT syndrome (SQTS) is a rare 
inherited channelopathy without structural heart 
disease. It is an autosomal dominant, primary elec-
trical disorder with a low degree of penetrance. It 
has a characteristic clinical-electrocardiographic-
-electrophysiological phenotype consisting of ir-
regular palpitations due to the frequent episodes of 
paroxysmal atrial fibrillation (AF), dizziness and/or 
sudden cardiac death (SCD). Affected individuals 
usually have a positive family history of syncope 
or SCD in first or second degree young relatives 
(younger than 40 years of age) with autopsy ne-
gative SCD.
Resting electrocardiograms (ECGs) have very 
short and uniform QT/QTc intervals (QTc inter-
val ≤ 330 ms with the exception of the calcium-
-dependent variants 4 and 5), absent or minimal 
ST segments, interval from J point to T wave peak 
(Jp-Tp) measured in the precordial lead with the 
T wave of greatest amplitude < 120 ms, possible 
tall T waves with narrow base similar to the T wave 
of moderate hyperkalemia (“desert tent T waves”), 
frequent early repolarization pattern [1], prolonga-
tion of Tpeak-Tend interval, possible presence of 
prominent U waves, and very frequent paroxysmal 
AF. Additionally, the ECG response to exercise is 
characterized by a discrete QT interval reduction 
with increases in heart rate.
Intracardiac electrophysiological studies (EPS) 
show extremely short atrial refractory period 
(< 140 ms) and ventricular refractory period 
(< 150 ms), as well as an increased inducibility of 
AF and ventricular fibrillation (VF). Atrial refrac-
tory periods of < 140 ms and ventricular effective 
refractory periods of < 150 ms are highly suspi-
cious of SQTS.
Finally, data from autopsies do not reveal any 
evidence of structural heart disease. A molecular 
autopsy, defined as whole-genome sequencing 
performed post-mortem for patients who have died 
suddenly of unknown causes, is mandatory in the 
cases where young people dying suddenly present 
with a normal heart (“mors sine materia”).
Major landmarks of the more  
recent cardiac channelopathy
In 1993, Algra et al. [2], after analyzing al-
most 670 registries of consecutive Holter ECG 
recordings, concluded that the increase in risk of 
SCD was present not only in cases of QT interval 
prolongation, but also in the cases of QT interval 
shortening below 400 ms.
In 1999, Bjerregaard and Gussak [3] was the 
first to discover this entity in a premature 4-year-
-old African American girl who presented deve-
lopmental retardation and several episodes of car-
diac arrest. Her ECG had gradual and paradoxical 
shortening of the QT interval with decreases in 
heart rate until reaching values of 216 ms (dece-
leration-dependent QT interval shortening) and 
transient anomalies of the T wave. She died prema-
turely, and the authors published their observations 
emphasizing the heart rate deceleration-dependent 
QT interval shortening. They speculated that 
this represented a new electrical phenomenon 
dependent on the inwardly-rectifying potassium 
channel (IK Arch) activation caused by an intense 
vagal discharge and responsible for bradycardia and 
QT interval shortening. They postulated that her 
death could be related to the short QT interval [4]. 
We think that this speculation is unlikely, because 
IK Arch channels are not expressed in ventricular 
cells. They are expressed primarily in the sinoatrial 
node, atrioventricular (AV) node, and atrial muscle 
cells causing hyperpolarization and action potential 
shortening, as well as negative chronotropic and 
dromotropic effects. IK Arch together with Ik Ado be-
longs to the inward-rectifying K (+) (Kir) channel 
family. These are activated by muscarinic (M2) and 
purinergic type 1 receptors via GTP regulatory (G) 
protein signal transduction.
In February 1999, a 17-year-old previously 
healthy Caucasian girl underwent laparoscopic 
cholelithiasis at the Anderson Hospital in Maryvil-
le, Illinois USA. At the end of the procedure she 
developed paroxysmal AF with rapid ventricular 
response (150–200 bpm) and acute pulmonary 
edema. DC cardioversion was conducted with 
success, and she was discharged on digoxin in 
sinus rhythm. After 45 days she had recurrence 
of AF and was referred to Dr Bjerregaard who 
noticed that she had an extremely short QTc (225 
ms). Therapy was started with propafenone. For 
6 months she remained asymptomatic without recur-
rence of AF, and propafenone was discontinued. Two 
months later, after a new episode of AF, treatment 
with propafenone was re-started. For more than 
4 years she remained asymptomatic on propafenone 
without any evidence of AF. In August 2003, after 
the publication by Gussak et al. [4], she underwent 
an electrophysiology study with induction of VF and 
received an intracardiac defibrillator (ICD).
Gussak et al. [5] presented a family where some 
of its members were carriers of persistent short QT 
intervals: a 17-year-old teenager with QT interval of 
240 ms that suffered several episodes of paroxysmal 
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AF requiring electric cardioversion; the 21-year-
-old brother was asymptomatic; the 51-year-old 
mother had a history of sustained palpitations and 
AF; and the maternal grandfather. An 84-year-old 
Italian Caucasian (QT interval of 240 ms) was in 
chronic AF related to hypertension and coronary 
artery disease and died of cerebral embolism years 
later. The authors described other manifestations of 
abnormally short QT intervals and mentioned the 
possible arrhythmogenic potential of this finding.
Gaita et al. [6] described several members of 
2 different families with symptoms of syncope, palpi-
tations and aborted cardiac arrest in the presence 
of positive family histories of SCD. All the patients 
had constant short QT/QTc intervals (QT interval 
£ 280 ms and QTc £ 300 ms). Finally, during an 
electrophysiology study, they verified that the re-
fractory periods, both atrial and ventricular, were 
very short, thus causing vulnerability to both atrial 
and VF. The autopsy did not reveal any underlying 
structural heart disease.
The same year, Schrimpf et al. [7] published 
the first experience of ICD implant in 5 members 
of 2 European families, revealing a high rate of 
inappropriate shocks by T-wave over sensing due 
to the high voltage of these waves.
In January 2004, Brugada et al. [8], working 
in the Masonic Medical Research Laboratory, 
described for the first time the genetic basis of 
this new entity characterized by SCD in infants, 
children, teenagers and young adults with short 
QT/QTc intervals. The entity is caused by 2 mis-
sense mutations in the KCNH2 (HERG) gene 
producing a dramatic gain in function in the rapid 
outward rectifier potassium channel known as Ikr 
and leading to a heterogeneous shortening of action 
potentials and consequently of QT/QTc intervals. 
The authors speculated that this could be another 
cause for the so-called sudden infant death syn-
drome (SIDS). This variant was called SQT1. The 
entity is the allelic mirror image of the congenital 
long QT syndrome variant 2 or LQT2.
In May 2004, Bellocq et al. [9] from Laborato-
ire de Physiopathologie et de Pharmacologie Cel-
lulaires et Moléculaires, Nantes, France, showed 
the genetic heterogeneity of the new entity by 
identifying a mutation in the KCNQ1 gene (g919c 
substitution) that causes an acceleration in the 
kinetics of function activation of the slow outward 
rectifier potassium channel Iks. This variant was 
called SQT2. It is the mirror image of congenital 
long QT syndrome type 1 or LQT1.
In November 2004, Viskin et al. [10] from the 
Department of Cardiology, Tel Aviv University’s 
Sackler Faculty of Medicine, Israel, compared QT 
interval duration in 28 patients with idiopathic 
VF (17 men) with normal controls. Short QT was 
defined as QTc £ 360 ms for men and £ 370 ms 
for women. The authors concluded that shorter 
QTc intervals values are commonly seen in male 
patients with idiopathic VF. However, short QTc 
values are not rare among healthy adults, especially 
at slow heart rates. Consequently, until today there 
is no answer to the authors’ question: Is idiopathic 
VF a short QT syndrome? A short QT interval 
has also been noticed in some other arrhythmic 
syndromes including Brugada syndrome and early 
repolarization syndrome, but the role of a short QT 
interval in these settings is not yet known [11].
In April 2005, Priori et al. [12] from Pavia 
University, Italy, identified a new familial variant 
called SQT3 which, unlike the previous variants, 
presented with asymmetrical high voltage T waves 
[13]. This new variant was caused by a mutation 
in the KCNJ2 or kir2.1 gene by G514A substitu-
tion that encodes the inward rectification of the 
Ik1 channel (human inwardly rectifying potassium 
channel KIR2). This mutation causes acceleration 
of the final phase of repolarization (gain in fun-
ction), thus shortening the duration of the action 
potential and QT interval of ECG. This variant is 
the counterpart of the Andersen-Tawil syndrome 
type 1, also caused by mutation in the KCNJ2 or 
kir2.1 gene and manifested by familial periodical 
paralysis, cardiac arrhythmias and development 
anomalies with micrognathia, dental anomalies, 
low-set ears, hypertelorism, clinodactyly, and po-
ssible short height and scoliosis.
The same year (2005), we presented the first 
case in Latin America [14], with complete right 
bundle branch block, and using the vectorcardio-
gram method, we showed that the T-loop limbs 
are asymmetrical (secondary T-loop) because the 
velocity of inscription of the efferent limb is slower 
(dashes closer to each other) than the afferent limb 
inscription velocity, as seen in the normal T-loop 
(Fig. 1).
The Holter monitoring demonstrated the 
presence of paroxysmal AF (Figs. 2, 3).
In January 2007, Antzelevitch et al. [15], from 
the Masonic Medical Research Laboratory in Utica, 
New York, identified a new variant with a not-so-
-short QTc interval (£ 360 ms) associated with 
the Brugada syndrome. Unlike the previous cases 
that affect potassium channels, this variant was 
associated with a loss of function in the slow inward 
calcium channel or L-type channel. The mutations 
are of the missense type in CACNA1C (A39V and 
ECD
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G490R) and CACNB2 (S481L) that encode alpha-1 
and beta2b subunits of the slow L-type Ca2+ channel 
(LTCC). This was the first report on mutations in 
the genes that encode the L-type calcium channel 
and is associated with a familial syndrome of SCD in 
which a Brugada syndrome phenotype is combined 
with discretely shorter QT intervals. These are 
considered the SQT4 and SQT5 variants. Genetic 
defects in the LTCC may also cause Timothy syn-
drome, Brugada syndrome, in Ca(v)1.3 1 associated 
with X-linked retinal disorder and deafness, and 
a mutation in Ca(v)1.4 causing diseases such as 
Figure 1. Electro-vectorcardiographic (ECG/VCG) correlation in horizontal plane in a patient with congenital short 
QT syndrome (SQTS). The precordial leads of ECG show the typical features of complete right bundle branch block 
(CRBBB): QRS duration > 120 ms, triphasic rSR’ pattern in V1 and wide final S waves in left precordial lead V5–V6. 
Additionally, tall T waves with narrow bases from V3 to V5 and very short QT/QTc intervals are observed. The QRS 
loop of VCG shows CRBBB: QRS-loop duration > 120 ms (This corresponds to 60 or more dashes, where 1 dash = 2 ms); 
“Grishman” or Kennedy VCG type I (afferent limb behind the X orthogonal line). Additionally, terminal appendage 
after 60 ms with delay (slow recording end conduction delay (ECD) located on right quadrants in “glove finger” shape. 
T-loop is asymmetric with the afferent limb having slower conduction velocity compared to the efferent one (less 
distance between dashes indicates the slower conduction velocity in the area of RVOT). This observation shows that 
the T wave is not symmetrical (pseudo-symmetrical).
Figure 2. Holter recording in a patient with short QT syndrome. There is a short period of paroxysmal atrial fibrillation. 
In this moment, the patient complained of irregular palpitations.
Figure 3. Holter recording in a patient with congenital short QT syndrome with spontaneous sinus rhythm during the 
same recording (8 h later).
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an incomplete form of congenital stationary night 
blindness.
Anttonen et al. [16] demonstrate an increased 
transmural dispersion of repolarization (TDR) and 
its electrocardiographic counterpart T-wave peak 
to T-wave end interval (TPE) in SQTS patients 
that in part explain increased vulnerability of SQTS 
patients to ventricular arrhythmias.
In May 2011, Templin et al. [17] from the Car-
diovascular Center, University of Zurich, Switzer-
land, identified what they called the SQT6 variant, 
characterized by mutations in the CACNA2D1 
gene that encodes the a(2) d-1 subunit of the 
LTCC. The ECG of the affected member of 
a single family revealed a QT interval of 317 ms 
(329 ms QTc) associated with tall, narrow and 
symmetrical T waves. The EPS showed short 
ventricular refractory periods and increased vul-
nerability to induce VF.
Gollob et al. [18] published a systematic review 
based on a comprehensive analysis of 61 reported 
cases in the English language from the MEDLINE 
database in order to develop diagnostic criteria for 
congenital SQTS to facilitate clinical evaluation of 
suspected cases. The score was established on the 
basis of clinical, electrocardiographic, and genetic 
criteria as follows:
 — Two electrocardiographic criteria: QT in-
terval corrected by Bazett’s formula < 370 ms 
(1 point), < 350 ms (2 points) and < 330 ms 
(3 points) and J point-T peak interval duration 
in ms: Jp-Tp, < 120 ms (1 point);
 — Four personal clinical history dates: hi-
story of sudden cardiac arrest (2 points), do-
cumented polymorphic VT or VF (2 points), 
unexplained syncope (1 point) and/or AF 
(1 point);
 — Three family history parameters: first-or 
second-degree relative with high probability 
of SQTS (2 points), first-or second-degree 
relative with autopsy negative SCD (1 point), 
and sudden infant death syndrome (1 point);
 — Two genetic findings: genotype-positive 
(2 points) and mutation of undetermined signi-
ficance in a culprit gene (1 point).
A score ≥ 4 points is considered high pro-
bability, 3 points intermediate probability and 
£ 2 points low probability of SQTS. For the indivi-
duals with 3 points, the authors recommend conti-
nued clinical and electrocardiographic vigilance in 
the proband and first-degree relatives.
These criteria when applied in the 61 reported 
cases of the cohort show a high sensitivity.
Possible limitations of the score
The use of the Bazett’s formula
A criticism to the use of the Bazett’s formula 
employed by the authors is based on the QT in-
tervals not shortened if the heart rate is faster. 
Consequently, the Bazett’s formula will overcor-
rect the QT interval significantly at any heart rate 
> 60 bpm, and attempts should always be made 
to record an ECG as close to 60 bpm as possible 
by obtaining data from Holter monitoring or using 
a beta-blocker [19]. Rate-dependence of the QT 
interval was recognized 93 years ago by Henry 
Cuthbert Bazett [20], calculating the heart rate-
-corrected QT interval QTB. This nonlinear formula, 
obtained from data in only 39 young men, is not 
www.cardiologyjournal.org 469
Andrés Ricardo Pérez-Riera et al., Landmarks of the newest arrhythmogenic cardiac channelopathy
accurate and overcorrects at high heart rates and 
undercorrects at low heart rates [21]. Additionally, 
in congenital SQTS the QT interval is not affec-
ted by the heart rate [20]; in other words, in this 
channelopathy a discrete QT interval reduction is 
observed with increases in heart rate.
Nonexistence of a control group
The study validation has the limitation of 
not having a control group made up of apparently 
healthy subjects with shorter-than-normal QTc 
intervals [22].
The exclusion of criteria  
with great diagnostic utility
The stress test is another parameter that 
should have been included by the authors, because 
adaptation of the QT interval to increased heart 
rate is abnormal in patients with SQTS, unlike nor-
mal subjects with short QT intervals. Very short 
atrial and ventricular effective periods (< 140 ms 
and < 150 ms respectively) are highly suspicious 
for SQTS. Therefore, these electrophysiologic 
criteria should have been included in the score to 
distinguish SQTS from healthy people with short 
QT intervals.
Exclusion of first or second degree  
relatives £ 40 years old without autopsy
The exclusion of the presence of SCD in a first 
or second degree relative £ 40 years of age in 
whom autopsy was not made, should not be exclu-
ded as criterion.
Exclusion of mixed subtypes
The study validation presents the limitation 
of not having included subtypes that do not affect 
the potassium channels; that is, the ones that affect 
the calcium (SQT4, SQT5 and SQT6) and sodium 
channels (SQT7).
We share the view of Veltman and Borggrefe 
[23] that Gollob’s score was clearly inspired by the 
diagnostic criteria for LQTS developed by Schwartz 
et al. [24] for LQTS: a ‘Schwartz score’ for SQTS.
In November 2012, Hong et al. [25] from The 
Second Affiliated Hospital of Nanchang University, 
China, identified the first variant of SQTS with 
concomitant Brugada-like pattern. This was asso-
ciated with a mutation in the alpha subunit of the 
SCN5A gene causing a loss of function and consi-
dered variant 7 or SQT7. In many cases, multiple 
biophysical defects with mutations in the SCN5A 
gene caused mixed channelopathy syndromes of 
the sodium channel: overlap syndrome of cardiac 
sodium channelopathy [26]. If we employ a crite-
rion encompassing variants with mixed phenotypes 
(overlapping phenotypes) it is reasonable to assume 
at least 7 variants of SQTS (Table 1).
Finally, we have recently observed the pre-
sence of T waves with particular features cha-
racterized by negative-positive or “minus-plus” 
polarity in some ECG tracings in the literature 
and in a recent family from Brazil (Fig. 3). This 
“minus-plus T-wave sign” appears as a biphasic 
negative/positive T wave following the QRS with 
absent ST segments (Figs. 4, 5). For now this 
electrocardiographic finding may have diagnostic 
value if the following question is considered: What 
is the utility of this finding? Does its presence help 
to make a diagnosis and/or prognosis? To answer 
this question it is necessary to systematically re-
view published electrocardiographic tracings and 
Holters to determine the frequency of the sign 
and how its presence contributes to diagnosis or 
prognosis.
Conclusions
Congenital SQTS is a channelopathy without 
structural heart disease and considered an elec-
Table 1. Congenital short QT syndrome variants. Modified from Courtesy Professor Charles Antzelevitch.
QTc duration [ms] Gene (cardiac ion channel) Reference
SQT1 286 ± 6 KCNH2 (IKr) [6]
SQT2 302 KCNQ1 (IKs) [7]
SQT3 315–330 KCNJ2 (IK1) [10]
SQT4 331–370 CACNB2b (ICa) [12]
SQT5 346–360 CACNA1C (ICa) [12]
SQT6 329 CACNA2D1 (ICa) [13]
SQT7 ? SCN5A [20]
Calcium and sodium channel mutations (SQT4/SQT5/SQT6 and SQT7) produce a combined SQTS/Brugada syndrome phenotype  
(overlapping phenotype)
Figure 4. Very short QT intervals, absent or minimal ST segments, tall peaked pseudo-symmetrical T waves or “hyper-
kalemic like T waves”. Additionally, in lead III “minus-plus T-wave sign” is observed.
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Figure 5. The “minus-plus T-wave signal” observed in a Holter recording in a patient from Latin America (Brazil).
trical heart disease. It is a rare autosomal familial 
syndrome of low penetrance associated with mu-
tations in genes that control potassium, calcium 
or sodium channels and characterized by clinical, 
electrocardiographic and electrophysiological ty-
pical features, and negative autopsy or “mors sine 
materia” where molecular autopsy is mandatory 
[27, 28].
In this chronological historical review we 
considered the main landmarks and showed how 
science has constructed the gradual clarification of 
this fascinating channelopathy. It is important to 
highlight that many cases of idiopathic VF could 
occur due to SQTS, and that the diagnosis is not 
always perceived even by experienced colleagues.
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